Torthaí cuardaigh - Ken Mills

Beachtaigh na torthaí
  1. 1
    The site of the breakpoint within the bcr is a prognostic factor in Philadelphia-positive CML patients [see comments]

    The site of the breakpoint within the bcr is a prognostic factor in Philadelphia-positive CML patients [see comments] de réir Ken Mills, ED MacKenzie, GD Birnie

    Foilsithe / Cruthaithe 1988
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Molecular pathogenesis of the myeloproliferative neoplasms

    Molecular pathogenesis of the myeloproliferative neoplasms de réir Graeme Greenfield, Mary Frances McMullin, Ken Mills

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Significance of NPM1 Gene Mutations in AML

    Significance of NPM1 Gene Mutations in AML de réir Andrew Hindley, Mark Catherwood, Mary Frances McMullin, Ken Mills

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Effects of the aurora kinase inhibitors AZD1152-HQPA and ZM447439 on growth arrest and polyploidy in acute myeloid leukemia cell lines and primary blasts

    Effects of the aurora kinase inhibitors AZD1152-HQPA and ZM447439 on growth arrest and polyploidy in acute myeloid leukemia cell lines and primary blasts de réir Elisabeth Walsby, V. Walsh, Chris Pepper, Alan K. Burnett, Ken Mills

    Foilsithe / Cruthaithe 2008
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort study

    Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort study de réir John Busby, Ken Mills, Shudong Zhang, Fabio Liberante, Chris R. Cardwell

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    The ruxolitinib effect: understanding how molecular pathogenesis and epigenetic dysregulation impact therapeutic efficacy in myeloproliferative neoplasms

    The ruxolitinib effect: understanding how molecular pathogenesis and epigenetic dysregulation impact therapeutic efficacy in myeloproliferative neoplasms de réir Graeme Greenfield, Suzanne McPherson, Ken Mills, Mary Frances McMullin

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Protein tyrosine phosphatase receptor type C (PTPRC or CD45)

    Protein tyrosine phosphatase receptor type C (PTPRC or CD45) de réir Maryam Ahmed Al Barashdi, Ahlam Ali, Mary Frances McMullin, Ken Mills

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    A Novel Ca2+-binding Protein, p22, Is Required for Constitutive Membrane Traffic

    A Novel Ca2+-binding Protein, p22, Is Required for Constitutive Membrane Traffic de réir Margarida Barroso, Karen K. Bernd, Natalie DeWitt, Andrea Chang, Ken Mills, Elizabeth Sztul

    Foilsithe / Cruthaithe 1996
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    The effects of lestaurtinib (CEP701) and PKC412 on primary AML blasts: the induction of cytotoxicity varies with dependence on FLT3 signaling in both FLT3-mutated and wild-type cases

    The effects of lestaurtinib (CEP701) and PKC412 on primary AML blasts: the induction of cytotoxicity varies with dependence on FLT3 signaling in both FLT3-mutated and wild-type cas... de réir Steven Knapper, Ken Mills, Amanda Gilkes, Steve J. Austin, V. Walsh, Alan K. Burnett

    Foilsithe / Cruthaithe 2006
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Comparison of four commercially available rapid enzyme immunoassays with cytotoxin assay for detection of Clostridium difficile toxin(s) from stool specimens

    Comparison of four commercially available rapid enzyme immunoassays with cytotoxin assay for detection of Clostridium difficile toxin(s) from stool specimens de réir C S Merz, Camille Kramer, Michael Forman, Linda Gluck, Ken Mills, K Senft, I. Steiman, Nancy M. Wallace, Patricia Charache

    Foilsithe / Cruthaithe 1994
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    Validation of Next Generation Sequencing Technologies in Comparison to Current Diagnostic Gold Standards for BRAF, EGFR and KRAS Mutational Analysis

    Validation of Next Generation Sequencing Technologies in Comparison to Current Diagnostic Gold Standards for BRAF, EGFR and KRAS Mutational Analysis de réir Clare McCourt, Darragh G. McArt, Ken Mills, Mark Catherwood, Perry Maxwell, David Waugh, Peter Hamilton, Joe M. O’Sullivan, Manuel Salto‐Tellez

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    Differential expression of<i>SHP-1</i>in chronic myeloid leukemia

    Differential expression of<i>SHP-1</i>in chronic myeloid leukemia de réir Jaspal Kaeda, Daniel Neuman, Simone Bonecker, Ken Mills, Christian Oberender, Leila Amini, Frauke Ringel, Anna Serra, Michaela Schwarz, Bernd Dörken, Ilana Zalcberg, Philipp le Coutre

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán
    Carta
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    Microarray-based classifiers and prognosis models identify subgroups with distinct clinical outcomes and high risk of AML transformation of myelodysplastic syndrome

    Microarray-based classifiers and prognosis models identify subgroups with distinct clinical outcomes and high risk of AML transformation of myelodysplastic syndrome de réir Ken Mills, Alexander Kohlmann, Paul Williams, Lothar Wieczorek, Wei‐Min Liu, Rachel Li, Wen Wei, David Bowen, H. Loeffler, Jesús María Hernández‐Rivas, Wolf‐Karsten Hofmann, Torsten Haferlach

    Foilsithe / Cruthaithe 2009
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    HOXA/PBX3 knockdown impairs growth and sensitizes cytogenetically normal acute myeloid leukemia cells to chemotherapy

    HOXA/PBX3 knockdown impairs growth and sensitizes cytogenetically normal acute myeloid leukemia cells to chemotherapy de réir Glenda J. Dickson, Fabio Liberante, Laura M. Kettyle, Kathleen O’Hagan, Damian Finnegan, Lars Bullinger, Dirk Geerts, Mary Frances McMullin, Terence R.J. Lappin, Ken Mills, Alexander Thompson

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    RARα-PLZF overcomes PLZF-mediated repression of <i>CRABPI</i> , contributing to retinoid resistance in t(11;17) acute promyelocytic leukemia

    RARα-PLZF overcomes PLZF-mediated repression of <i>CRABPI</i> , contributing to retinoid resistance in t(11;17) acute promyelocytic leukemia de réir Fabien Guidez, Sarah Parks, Henna Wong, Jelena Jovanović, Ashley N. Mays, Amanda Gilkes, Ken Mills, Marie-Claude Guillemin, Robin M. Hobbs, Pier Paolo Pandolfi, Hugues de Thé, Ellen Solomon, David Grimwade

    Foilsithe / Cruthaithe 2007
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    Oncogenic roles of <scp>PRL</scp> ‐3 in <scp>FLT</scp> 3‐ <scp>ITD</scp> induced acute myeloid leukaemia

    Oncogenic roles of <scp>PRL</scp> ‐3 in <scp>FLT</scp> 3‐ <scp>ITD</scp> induced acute myeloid leukaemia de réir Jung Eun Park, Hiu Fung Yuen, Jian Zhou, Abdul Qader Al-Aidaroos, Ke Guo, Peter J.M. Valk, Shudong Zhang, Wee Joo Chng, Cheng William Hong, Ken Mills, Qi Zeng

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemia

    Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemia de réir Rosemary E. Gale, Robert K. Hills, Arnold Pizzey, Panagiotis Kottaridis, David Swirsky, Amanda Gilkes, E Nugent, Ken Mills, Keith Wheatley, Ellen Solomon, Alan K. Burnett, David C. Linch, David Grimwade

    Foilsithe / Cruthaithe 2005
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors

    Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors de réir Katrina M. Lappin, Eliana M. Barros, Satpal S. Jhujh, Gareth Irwin, Hayley McMillan, Fabio Liberante, Cheryl Latimer, Melissa J. La Bonte, Ken Mills, D. Paul Harkin, Grant S. Stewart, Kienan I. Savage

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    Apolipoprotein E abundance is elevated in the brains of individuals with Down syndrome–Alzheimer’s disease

    Apolipoprotein E abundance is elevated in the brains of individuals with Down syndrome–Alzheimer’s disease de réir Clíona Farrell, Yazead Buhidma, Paige Mumford, Wendy Heywood, Jenny Hällqvist, Lisi Flores Aguilar, Elizabeth J. Andrews, Negin Rahimzadah, Orjona Taso, Eric Doran, Vivek Swarup, Elizabeth Head, Tammaryn Lashley, Ken Mills, Christina E. Toomey, Frances K. Wiseman

    Foilsithe / Cruthaithe 2025
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  20. 20
    Identification of Gene Expression–Based Prognostic Markers in the Hematopoietic Stem Cells of Patients With Myelodysplastic Syndromes

    Identification of Gene Expression–Based Prognostic Markers in the Hematopoietic Stem Cells of Patients With Myelodysplastic Syndromes de réir Andrea Pellagatti, Axel Benner, Ken Mills, Mario Cazzola, Aristoteles Giagounidis, Janet Perry, Luca Malcovati, Matteo Giovanni Della Porta, Martin Jädersten, Amit Verma, Emma-Jane McDonald, Sally Killick, Eva Hellström‐Lindberg, Lars Bullinger, James S. Wainscoat, Jacqueline Boultwood

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: